REFERENCES
- Brendel , D. H. and Miller , F. G. 2008 . A plea for pragmatism in clinical research ethics . American Journal of Bioethics , 8 ( 4 ) : 24 – 31 .
- Dunlop , B. and Banja , J. 2009 . A renewed, ethical defense of placebo-controlled trials of new treatments for major depression and anxiety disorders . Journal of Medical Ethics. , 35 ( 6 )
- Freedman , A. , Fuks , A. and Weijer , C. 1992 . Demarcating research and treatment: A systematic approach for the analysis of the ethics of clinical research . Clinical Research , 40 : 653 – 660 .
- Liao , S. M. , Sheehan , M. and Clarke , S. 2009 . The duty to disclose adverse clinical trials results . American Journal of Bioethics , 9 ( 8 ) : 24 – 32 .
- Miller , F. G. and Brody , H. 2002 . What makes placebo-controlled trials unethical? . American Journal of Bioethics , 2 : 3 – 9 .
- Office for Human Research Protections . 2007 . Guidance on Reviewing and Reporting Unanticipated Problems Involving Risks to Subjects or Others and Adverse Events Available at: http://www.hhs.gov/ohrp/policy/AdvEvntGuid.htm(accessed March 25, 2009)
- Rothman , K. J. and Michels , K. B. 1994 . The continuing unethical use of placebo controls . New England Journal of Medicine , 331 : 394 – 398 .
- Schofferman , J. and Banja , J. 2008 . Conflicts of interest in pain medicine: Practice patterns and relationships with industry . Pain , 139 : 494 – 497 .
- Trivedi , M. H. , Rush , A. J. Wisniewski , S. R. 2006 . Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice . American Journal of Psychiatry , 163 : 28 – 40 .
- Weijer , C. and Crouch , R. A. 1999 . Why should we include women and minorities in randomized controlled trials? . Journal of Clinical Ethics , 10 : 100 – 106 .